000 01440 a2200385 4500
005 20250516220310.0
264 0 _c20150915
008 201509s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.03408-14
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDutta, Noton K
245 0 0 _aSterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cSep 2014
300 _a5567-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aIsoniazid
_xtherapeutic use
650 0 4 _aLung
_xmicrobiology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aPyrazinamide
_xtherapeutic use
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aThioridazine
_xtherapeutic use
650 0 4 _aTuberculosis, Pulmonary
_xdrug therapy
700 1 _aPinn, Michael L
700 1 _aKarakousis, Petros C
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 58
_gno. 9
_gp. 5567-9
856 4 0 _uhttps://doi.org/10.1128/AAC.03408-14
_zAvailable from publisher's website
999 _c23925766
_d23925766